Pfizer raises 2026 outlook to $62B-$64B revenue and $2.95-$3.05 adjusted EPS, targeting high single-digit revenue CAGR from 2028-2033

Unilever eyes €1B in savings as post-spin-off restructuring gathers pace

Ultragenyx outlines 2027 profitability plan with R&D under $350M and SG&A under $375M following GTX-102 discontinuation

China’s services PMI misses expectations at 50.8 in October, composite PMI drops to 52.0

Asia stocks tumble as tech shares slide on U.S. election results